Free Daily Headlines :

  • COVID-19
  • Vaccine Info
  • Money
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Vaccine Info
    Money
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism

Jepsen sues Purdue, saying it reaped profits by boosting opioid addiction

  • Health
  • by Ana Radelat
  • December 20, 2018
  • View as "Clean Read" "Exit Clean Read"

Connecticut became the latest state on Thursday to sue Stamford-based Purdue Pharma, saying the company purposefully downplayed the risks of addiction of OxyContin and other opioid painkillers.

The suit filed by Connecticut Attorney General George Jepsen in Superior Court in Hartford alleges Purdue “peddled a series of falsehoods” to push patients toward its opioids, reaping massive profits from sales while opioid addiction skyrocketed to the crisis level that is currently impacting Connecticut and states across the country.

The lawsuit also names current and former board members as defendants, alleging that they tracked sales representatives and oversaw the company’s sale tactics on opioid drugs. Those named include members of the Sackler family that owns the company, including Richard Sackler, Jonathan Sackler, Mortimer D.A. Sackler, Kathe Sackler, Ilene Sackler Lefcourt, Beverly Sackler, David Sackler and  Theresa Sackler. The lawsuit also names past CEOs John Stewart and Mark Timney as defendants.

“We vigorously deny the state’s allegations,” Purdue said in a statement.  “The state claims Purdue acted improperly by communicating with prescribers about scientific and medical information that FDA has expressly considered and continues to approve. We believe it is inappropriate for the state to substitute its judgment for the judgment of the regulatory, scientific and medical experts at FDA. We look forward to the opportunity to present our substantial defenses.”

Purdue also said the company’s opioid medicines “account for less than 2 percent of total prescriptions,” and said it “will continue to work collaboratively with the state toward bringing meaningful solutions to address this public health challenge.”

More than 25 states have sued Purdue, as have dozens of counties and towns, including about 20 in Connecticut. Those include Waterbury, Bristol, East Hartford, Torrington, Bridgeport and New Britain, among others.

Some of those Connecticut towns, including Waterbury, Bristol and Torrington, chose like Jepsen to pursue their claims in state court because Purdue Pharma is based here and they think the company’s liability risk is greatest in state court.  The others are suing in federal court and are part of the consolidation of those suits, now before a federal judge in Cleveland.

Jepsen is also suing Purdue over its marketing and distribution of two other painkillers besides the popular OxyContin —  Butrans and Hysingla.

Purdue said it ended its speaker programs, which tapped doctors to promote the prescription of these pain killers to other medical professionals at the end of 2016 and 2017.

Before filing the lawsuit, Jepsen was part of a multi-state investigation into Purdue. He said in a statement released Thursday that the states  tried to reach a settlement with the pharmaceutical giant.

“For a number of months, Connecticut and our multi-state partners have been engaged in intensive negotiations with opioid manufacturers and distributors in the hope of resolving potential legal claims in a way that would avoid protracted litigation and would bring opioid treatment resources to those who are desperately in need,” Jepsen said.

The Connecticut attorney general said, however,  “Purdue Pharma … has not demonstrated to me that it is serious about addressing the states’ very real allegations of misconduct and coming to a meaningful settlement.”

Jepsen also said he expected negotiations with Purdue to continue while the case makes its way through Superior Court.

Connecticut’s lawsuit against Purdue alleges the company led patients and doctors to believe that opioids were safe to treat even minor pain, and that patients could and should take higher and more dangerous doses. The state also alleges that Purdue sent sales representatives to doctors’ offices, clinics, pharmacies and hospitals in Connecticut to make ”deceptive” sales pitches about opioid drugs.

It said the company rewarded high-prescribing doctors with attention, meals, gifts and money; and gave bonuses to sales representatives who generated the most opioid prescriptions.

The company did not tell doctors that higher doses of opioids carried a heightened risk of addiction, overdose and death, the Connecticut lawsuit said.

Sign up for CT Mirror's free daily news summary.

Free to Read. Not Free to Produce.

The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.

YES, I'LL DONATE TODAY

ABOUT THE AUTHOR

Ana Radelat Ana has written about politics and policy in Washington, D.C.. for Gannett, Thompson Reuters and UPI. She was a special correspondent for the Miami Herald, and a regular contributor to The New York TImes, Advertising Age and several other publications. She has also worked in broadcast journalism, for CNN and several local NPR stations. She is a graduate of the University of Maryland School of Journalism.

SEE WHAT READERS SAID

RELATED STORIES
Current K-12 students could claim religious exemption to vaccines under amended bill
by Jenna Carlesso

The legislation, which is expected to pass the House, would remove the religious exemption beginning in September 2022.

Biden moves to overturn Trump birth control rules
by Julie Rovner | Kaiser Health News

The Biden administration has formally proposed the repeal of Trump-era regulations barring abortion referrals.

New Britain residents weren’t getting vaccinated. So city officials got creative.
by Dave Altimari

The city's efforts are a microcosm of what is happening across the country as officials struggle to vaccinate vulnerable residents.

CT lawmakers call for funding to stop ‘mass killing’ of Black and brown children
by Kelan Lyons

Lawmakers identified a $5 billion proposal by the Biden administration, and marijuana and sports-betting legalization efforts, as potential funding.

CT’s prison population shrunk during the pandemic. Will it last?
by Kelan Lyons and Kasturi Pananjady

The historic declines coincide with a demand for equity as racial disparities in the incarcerated populate have widened during COVID-19.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion Redistricting in Connecticut 2021: It is worth your attention
by Patricia Rossi

This is the year for redistricting in the United States. Maps drawn in 2021 will define which voters can vote for which candidates for the next ten years.  That means ensuring that the 2021 maps are fair and representative of their communities is critically important.

Opinion Lembo: Legislators should let constituents share the success of their health plan.
by Comptroller Kevin Lembo

The health care crisis in Connecticut continues. Bills under consideration in Connecticut expand subsidies, attempt to lower prescription drug costs and address long-standing health care inequities. There is room to incorporate the best of each if it helps make health care in our state more affordable, equitable and accessible. But Senate Bill 842 is the only bill that provides short and long-term help for small businesses, nonprofits and certain labor unions.

Opinion Will the Comptroller open the state-run healthcare plan’s books?
by Wyatt Bosworth

What choices do you have when you cannot defend a policy issue on its merits? One path is that chosen by former New Britain Democratic Town Committee chair Bill Shortell in his April 14 Viewpoints opinion piece, “Debunking the CBIA’s takedown of the public option healthcare bill.” Instead of defending any perceived merits associated with the proposed expansion of state-run healthcare in Connecticut, Shortell attacks the messenger. In this case, two organizations that have raised legitimate —and unanswered— questions about that proposal.

Opinion Climate action now to insure Connecticut’s future
by Commissioners Andrew Mais and Katie Dykes

Connecticut has had nine weather-related federal disaster declarations in the past 11 years, totaling more than $362 million in damages. For Storms Irene, Sandy, and the 2011 October Nor’easter, insurers paid out more than $1 billion to cover insured damages in Connecticut. The climate crisis is upon us. The science is clear. We must act now.

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO